$ARWR
ARROWHEAD PHARMACEUTICALS, INC. Stock $arwr

$arwr Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000119312513055330 Filed on February 13, 2013

Income Statement

Concept	2013 Q1	2012 Q4	2011 Q4
Revenue	$43.75K	$159.0K	$23.96K
YoY Change	40.0%	563.73%	-92.01%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.790M	$1.900M	$2.110M
YoY Change	-42.63%	-9.95%	62.31%
% of Gross Profit
Research & Development	$2.125M	$1.577M	$769.1K
YoY Change	56.4%	105.01%	-65.97%
% of Gross Profit
Depreciation & Amortization	$448.8K	$449.6K	$454.4K
YoY Change	5.85%	-1.07%	354.44%
% of Gross Profit
Operating Expenses	$5.434M	$4.969M	$4.063M
YoY Change	10.9%	22.3%	11.93%
Operating Profit	-$5.390M	-$4.810M	-$4.039M
YoY Change	10.71%	19.09%
Interest Expense	-$210.0K	-$10.00K	-$220.0K
YoY Change	-69.12%	-95.45%	-141.51%
% of Operating Profit
Other Income/Expense, Net	-$1.549M	$29.31K	$1.352M
YoY Change	116.74%	-97.83%
Pretax Income	-$6.940M	-$4.781M	-$2.687M
YoY Change	24.29%	77.95%	-4.39%
Income Tax
% Of Pretax Income
Net Earnings	-$6.758M	-$4.614M	-$2.486M
YoY Change	26.67%	85.64%	72.6%
Net Earnings / Revenue	-15446.71%	-2901.69%	-10374.43%
Basic Earnings Per Share	-$0.41	-$0.33	-$0.25
Diluted Earnings Per Share	-$410.7K	-$290.5K	-$246.0K
COMMON SHARES
Basic Shares Outstanding	17.31M shares	15.64M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q1	2012 Q4	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.300M	$3.000M	$6.800M
YoY Change	-10.81%	-55.88%	23.64%
Cash & Equivalents	$3.313M	$2.931M	$6.773M
Short-Term Investments	$0.00	$100.0K	$100.0K
Other Short-Term Assets	$400.0K	$500.0K	$300.0K
YoY Change	-20.0%	66.67%	50.0%
Inventory
Prepaid Expenses
Receivables	$0.00	$115.3K
Other Receivables	$0.00	$2.500M
Total Short-Term Assets	$3.740M	$6.064M	$9.200M
YoY Change	-57.5%	-34.09%	-16.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.013M	$4.427M	$6.900M
YoY Change	-40.1%	-35.85%	6800.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$1.900M
YoY Change	-100.0%	-100.0%	-5.0%
Other Assets	$4.666M	$4.740M	$0.00
YoY Change
Total Long-Term Assets	$8.679M	$9.167M	$13.90M
YoY Change	-23.19%	-34.05%	230.95%
TOTAL ASSETS
Total Short-Term Assets	$3.740M	$6.064M	$9.200M
Total Long-Term Assets	$8.679M	$9.167M	$13.90M
Total Assets	$12.42M	$15.23M	$23.10M
YoY Change	-38.21%	-34.06%	51.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$871.7K	$809.5K	$700.0K
YoY Change	8.96%	15.65%	-70.83%
Accrued Expenses	$823.5K	$842.6K	$3.000M
YoY Change	-76.47%	-71.91%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.100M	$1.200M	$200.0K
YoY Change	450.0%	500.0%	-60.0%
Total Short-Term Liabilities	$7.164M	$6.078M	$5.100M
YoY Change	11.94%	19.18%	-35.44%
LONG-TERM LIABILITIES
Long-Term Debt	$1.200M	$1.300M	$2.100M
YoY Change	-42.86%	-38.1%
Other Long-Term Liabilities	$272.2K	$270.9K	$100.0K
YoY Change		170.93%
Total Long-Term Liabilities	$1.495M	$1.549M	$2.200M
YoY Change	-28.82%	-29.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.164M	$6.078M	$5.100M
Total Long-Term Liabilities	$1.495M	$1.549M	$2.200M
Total Liabilities	$8.659M	$7.627M	$6.900M
YoY Change	11.01%	10.53%	-2.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$146.4M	-$139.6M
YoY Change
Common Stock	$151.7M	$150.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.313M	$8.975M	$16.20M
YoY Change
Total Liabilities & Shareholders Equity	$12.42M	$15.23M	$23.10M
YoY Change	-38.21%	-34.06%	51.97%

Cashflow Statement

Concept	2013 Q1	2012 Q4	2011 Q4
OPERATING ACTIVITIES
Net Income	-$6.758M	-$4.614M	-$2.486M
YoY Change	26.67%	85.64%	72.6%
Depreciation, Depletion And Amortization	$448.8K	$449.6K	$454.4K
YoY Change	5.85%	-1.07%	354.44%
Cash From Operating Activities	-$4.500M	-$3.800M	-$2.700M
YoY Change	7.14%	40.74%	92.86%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$9.439K	$69.42K
YoY Change	-100.0%	-86.4%
Acquisitions
YoY Change
Other Investing Activities	$1.200M	$100.0K	$600.0K
YoY Change		-83.33%
Cash From Investing Activities	$1.200M	$100.0K	$500.0K
YoY Change	-700.0%	-80.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$3.500M	$4.100M	$1.464M
YoY Change		180.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.700M	3.300M	1.400M
YoY Change	208.33%	135.71%
NET CHANGE
Cash From Operating Activities	-4.500M	-3.800M	-2.700M
Cash From Investing Activities	1.200M	100.0K	500.0K
Cash From Financing Activities	3.700M	3.300M	1.400M
Net Change In Cash	400.0K	-400.0K	-800.0K
YoY Change	-112.5%	-50.0%	-42.86%
FREE CASH FLOW
Cash From Operating Activities	-$4.500M	-$3.800M	-$2.700M
Capital Expenditures	$0.00	$9.439K	$69.42K
Free Cash Flow	-$4.500M	-$3.809M	-$2.769M
YoY Change	12.5%	37.55%	97.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2008Q4	arwr	Additional Invest In Notes Offering AdditionalInvestInNotesOffering	600000
CY2008Q4	arwr	Invest In Notes Offering InvestInNotesOffering	200000
CY2008Q4	arwr	Principal Amount Of Note Not Converted In To Shares PrincipalAmountOfNoteNotConvertedInToShares	500000
CY2008Q4	arwr	Unsecured Convertible Promissory Note Agreements UnsecuredConvertiblePromissoryNoteAgreements	2500000
CY2011Q1	arwr	Contingent Amount To Be Received Under Discontinued Business ContingentAmountToBeReceivedUnderDiscontinuedBusiness	140000000
CY2011Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	50000
CY2012Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.76
CY2012Q4	arwr	Warrants Issued To Acquire Common Stock WarrantsIssuedToAcquireCommonStock	912543	shares
CY2008Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7054	shares
CY2008Q2	arwr	Common Stock Purchased From Minority Share Holders CommonStockPurchasedFromMinorityShareHolders	200000	shares
CY2008Q2	arwr	Value Of Common Stock Purchased By Cash ValueOfCommonStockPurchasedByCash	200000
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17311209	shares
CY2009Q4	arwr	Upfront Consideration Of Discontinued Operation UpfrontConsiderationOfDiscontinuedOperation	350000
CY2010Q1	arwr	Warrants Exercised WarrantsExercised	24788	shares
CY2010Q1	arwr	Stock Issued Against Warrants StockIssuedAgainstWarrants	12870	shares
CY2010Q2	arwr	Warrants Issued To Acquire Common Stock WarrantsIssuedToAcquireCommonStock	329649	shares
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6773126
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.61
CY2012Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	69623
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145000000	shares
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	935329
CY2012Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	256846
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7604479
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1067763
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	164671
CY2012Q4	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	150000000	shares
CY2012Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1490584
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5138195	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4710454
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6077978
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	460922
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	240000
CY2012Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	256846
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	109375
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-139611839
CY2012Q4	us-gaap	Assets Assets	15231131
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2931032
CY2012Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	323376
CY2012Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	1444161
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	470154
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.00
CY2012Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	256846
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	115266
CY2012Q4	us-gaap	Minority Interest MinorityInterest	-1370301
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	300000
CY2012Q4	us-gaap	Business Acquisition Contingent Consideration Potential Cash Payment BusinessAcquisitionContingentConsiderationPotentialCashPayment
CY2012Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3117322
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1914794	shares
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6367948
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4740465
CY2012Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	256846
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	222000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15231131
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15644158	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	270931
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	457961
CY2012Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	-139720
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	110420
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	606345
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	887102	shares
CY2012Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2012Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1548674
CY2012Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	30011
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	445921
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2749409
CY2012Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	322150	shares
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	50000
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	250000
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1000000
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	434229
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	216419
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	842639
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2012Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	2.12
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4426683
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	270056
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15644158	shares
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	56008
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	280000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	6063983
CY2012Q4	us-gaap	Business Acquisition Purchase Price Allocation Preacquisition Contingency Accrual BusinessAcquisitionPurchasePriceAllocationPreacquisitionContingencyAccrual
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2563106
CY2012Q4	us-gaap	Other Receivables OtherReceivables	9305
CY2012Q4	us-gaap	Business Acquisition Contingent Consideration At Fair Value BusinessAcquisitionContingentConsiderationAtFairValue	173621
CY2012Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	300000
CY2012Q4	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	1500000
CY2012Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	192634
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1941265
CY2012Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2491450
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	149976199
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	8974780
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1593132
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1227743
CY2012Q4	arwr	Unit Sold Description UnitSoldDescription	Each unit consisted of one share of Common Stock and a warrant to purchase
CY2010Q3	arwr	Monthly Remuneration Of Employee MonthlyRemunerationOfEmployee	10000
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145000000	shares
CY2012Q3	us-gaap	Minority Interest MinorityInterest	-1203733
CY2003Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1419762
CY2004Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11227149
CY2005Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28026657
CY2012Q3	us-gaap	Notes Payable Current NotesPayableCurrent	100000
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	809524
CY2012Q4	arwr	Operating Leases Future Minimum Payments Due In Six Years OperatingLeasesFutureMinimumPaymentsDueInSixYears	359370
CY2006Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31605644
CY2007Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26456577
CY2008Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12302609
CY2012Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8808909
CY2012Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1127219
CY2012Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	647213
CY2012Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4784569
CY2012Q4	arwr	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	0
CY2009Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4857936
CY2010Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8078295
CY2011Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12564167
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7507389
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5327888
CY2012Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	618130
CY2012Q4	arwr	Price Per Share Of Stock Issued In Underwritten Public Offering PricePerShareOfStockIssuedInUnderwrittenPublicOffering	2.26
CY2012Q4	arwr	Promissory Notes PromissoryNotes	500000
CY2012Q4	arwr	Warrant To Purchase Share Of Common Stock WarrantToPurchaseShareOfCommonStock	0.5	shares
CY2012Q4	arwr	Business Acquisition Net Change In Fair Value Of Contingent Consideration BusinessAcquisitionNetChangeInFairValueOfContingentConsideration
CY2012Q4	arwr	Operating Leases Future Minimum Payments Due In Six Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInSixYearsAndThereafter	125415
CY2012Q4	arwr	Research Equipment ResearchEquipment	3225540
CY2012Q4	arwr	Finite And Indefinite Lived Intangible Assets Net Ending Balance FiniteAndIndefiniteLivedIntangibleAssetsNetEndingBalance	4710454
CY2012Q4	arwr	Minimum Stock Price Required To Maintain Under Equity Line Facility MinimumStockPriceRequiredToMaintainUnderEquityLineFacility	2.00
CY2012Q4	arwr	Capital Leases Future Minimum Payments Due In Six Years CapitalLeasesFutureMinimumPaymentsDueInSixYears	256846
CY2012Q4	arwr	Capital Leases Future Minimum Payments Due In Six Years And Thereafter CapitalLeasesFutureMinimumPaymentsDueInSixYearsAndThereafter	107019
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.03
CY2011Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	729096	shares
CY2011Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1731211
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	69623
CY2012Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	37500
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-134997680
CY2012Q3	us-gaap	Assets Assets	16527818
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3377288
CY2012Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	323376
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.01
CY2012Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9375
CY2012Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2012Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1667247
CY2012Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1282458
CY2012Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2260869	shares
CY2012Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6200000
CY2012Q3	arwr	Common Stock Exercise Price CommonStockExercisePrice	3.25
CY2012Q3	arwr	Common Stock Exchange For Warrants CommonStockExchangeForWarrants	0.75	shares
CY2012Q3	us-gaap	Business Acquisition Contingent Consideration Potential Cash Payment BusinessAcquisitionContingentConsiderationPotentialCashPayment
CY2012Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3117322
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1910794	shares
CY2012Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6461435
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5064830
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16527818
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13579185	shares
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	108354
CY2012Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1592394
CY2012Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2391021
CY2012Q3	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	280261
CY2012Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2749409
CY2012Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	839421
CY2012Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	214801
CY2012Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	730775
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4895652
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13579185	shares
CY2012Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	106500
CY2012Q3	us-gaap	Assets Current AssetsCurrent	6567336
CY2012Q3	us-gaap	Business Acquisition Purchase Price Allocation Preacquisition Contingency Accrual BusinessAcquisitionPurchasePriceAllocationPreacquisitionContingencyAccrual	173621
CY2012Q3	us-gaap	Other Receivables OtherReceivables	9930
CY2012Q3	us-gaap	Business Acquisition Contingent Consideration At Fair Value BusinessAcquisitionContingentConsiderationAtFairValue	173621
CY2012Q3	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	1016000
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1565783
CY2012Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2446113
CY2012Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	145917968
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	10012642
CY2012Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	269142
CY2012Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	877986
CY2012Q3	arwr	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	0
CY2012Q3	arwr	Business Acquisition Net Change In Fair Value Of Contingent Consideration BusinessAcquisitionNetChangeInFairValueOfContingentConsideration
CY2012Q3	arwr	Research Equipment ResearchEquipment	3319027
CY2012Q3	arwr	Finite And Indefinite Lived Intangible Assets Net Ending Balance FiniteAndIndefiniteLivedIntangibleAssetsNetEndingBalance	4784569
CY2011Q1	arwr	Non Cash Consideration Received In Sale Of Interest In Subsidiary NonCashConsiderationReceivedInSaleOfInterestInSubsidiary	2500000
CY2011Q4	arwr	Debt Instrument Due Date DebtInstrumentDueDate	2014-10-17
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1187972
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	1579365
	us-gaap	Interest Paid InterestPaid	291802
	us-gaap	Share Based Compensation ShareBasedCompensation	13977143
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-79715382
CY2012Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	13000
CY2012Q3	arwr	Capital Lease Term Of Lease CapitalLeaseTermOfLease	P5Y
CY2012Q3	arwr	Percentage Of Increase In Annual Rental Cost PercentageOfIncreaseInAnnualRentalCost	0.03	pure
CY2009Q4	arwr	Reimbursements Of Patent And License Expenses ReimbursementsOfPatentAndLicenseExpenses	80000
CY2012Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2013-02-01
CY2012Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3900000
CY2012Q4	arwr	Stock Issued During Period Shares New Issues By Way Of Public Offering StockIssuedDuringPeriodSharesNewIssuesByWayOfPublicOffering	1800000	shares
	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	10529594
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2931032
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2757860
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32270891
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7858883
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1144369
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-46890180
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	15851555
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	359375
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	250000
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	1642775
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	115654
	us-gaap	Profit Loss ProfitLoss	-158433732
	us-gaap	Income Taxes Paid IncomeTaxesPaid	742500
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44195414
	us-gaap	Other Income OtherIncome	272685
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-1677000
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	323891
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3217747
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	303440
	us-gaap	Operating Income Loss OperatingIncomeLoss	-122026034
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-42838072
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	790625
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3313609
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	132754341
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	249704
	us-gaap	Net Income Loss NetIncomeLoss	-139447879
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6430374
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5851
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	10150000
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-115595660
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	62954
	us-gaap	Operating Expenses OperatingExpenses	126323884
	us-gaap	Revenues Revenues	4297850
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2024
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	3325679
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-18985853
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-50773
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	4708588
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-60542
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4054748
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1026964
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	741632
	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	-1026964
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-46003805
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18575915
CY2009	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	2000000
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2676170
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-115595660
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	18888265
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	2000000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2543142
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4270000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	28021553
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-47546660
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	832774
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	429851
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	109585478
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	554105
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	762954
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-42838072
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2516467
	arwr	Non Cash Impairment Charges NonCashImpairmentCharges	1642775
	arwr	Provision For Allowance For Bad Debts And Sales Related Allowances ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances	2497300
	arwr	Noncontrolling Interest NoncontrollingInterest	18985853
	arwr	Gain On Acquisition GainOnAcquisition	1576107
	arwr	Gain Loss From Sale Of Subsidiary GainLossFromSaleOfSubsidiary	306344
	arwr	Gain Loss On Sale Of Stock In Subsidiary GainLossOnSaleOfStockInSubsidiary	2292800
	arwr	Proceeds From Sale Of Stock In Subsidiary ProceedsFromSaleOfStockInSubsidiary	20902100
CY2003	us-gaap	Profit Loss ProfitLoss	-95238
CY2005	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	508513
CY2005	us-gaap	Net Income Loss NetIncomeLoss	-6733427
CY2005	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000
CY2005	us-gaap	Adjustments To Additional Paid In Capital Reallocation Of Minority Interest AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest	230087
CY2006	us-gaap	Profit Loss ProfitLoss	-19961961
CY2006	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	341537
CY2006	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1369478
CY2007	us-gaap	Profit Loss ProfitLoss	-30712947
CY2007	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	434727
CY2007	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2175544
CY2007	us-gaap	Adjustments To Additional Paid In Capital Reallocation Of Minority Interest AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest	2401394
CY2009	us-gaap	Profit Loss ProfitLoss	-19308392
CY2009	us-gaap	Adjustments To Additional Paid In Capital Reallocation Of Minority Interest AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest	16297
CY2010	us-gaap	Profit Loss ProfitLoss	-6957038
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7631
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1582149
CY2010	us-gaap	Minority Interest Increase From Stock Issuance MinorityInterestIncreaseFromStockIssuance	300000
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1066050
CY2011	us-gaap	Profit Loss ProfitLoss	-3492399
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13884
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1404640
CY2011	us-gaap	Minority Interest Increase From Stock Issuance MinorityInterestIncreaseFromStockIssuance	254275
CY2011	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-1618509
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	43279
CY2011	arwr	Remuneration Paid RemunerationPaid	120000
CY2004	us-gaap	Profit Loss ProfitLoss	-751255
CY2004	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15000
CY2004	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	175653
CY2004	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	991318
CY2008	us-gaap	Profit Loss ProfitLoss	-27241639
CY2008	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	290027
CY2008	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3187397
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4883	shares
CY2012	us-gaap	Profit Loss ProfitLoss	-22110723
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.20
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1229500	shares
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23833
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.40
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1241404
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	11.77
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	42919	shares
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50406
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	293964
CY2012	arwr	Remuneration Paid RemunerationPaid	120000
CY2012	arwr	Finite And Indefinite Lived Intangible Assets Net Beginning Balance FiniteAndIndefiniteLivedIntangibleAssetsNetBeginningBalance	1731211
CY2011Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	454444
CY2011Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	346551
CY2011Q4	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-420
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2011Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1
CY2011Q4	us-gaap	Profit Loss ProfitLoss	-2686799
CY2011Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	769074
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2011Q4	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	-100035
CY2011Q4	us-gaap	Interest Paid InterestPaid	10300
CY2011Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10121069	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2011Q4	us-gaap	Share Based Compensation ShareBasedCompensation	251878
CY2011Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2705356
CY2011Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-734263
CY2011Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	30070
CY2011Q4	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	539620
CY2011Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4039039
CY2011Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-220
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2011Q4	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	509009
CY2011Q4	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1431893
CY2011Q4	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	39940
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	-2485505
CY2011Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1352461
CY2011Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-172230
CY2011Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2686579
CY2011Q4	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-58091
CY2011Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1266908
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.00	pure
CY2011Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7875
CY2011Q4	us-gaap	Operating Expenses OperatingExpenses	4062997
CY2011Q4	us-gaap	Revenues Revenues	23958
CY2011Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3783
CY2011Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2011Q4	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-66904
CY2011Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-201294
CY2011Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	69424
CY2011Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-106527
CY2011Q4	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	-106527
CY2011Q4	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-420
CY2011Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	251878
CY2011Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2686579
CY2011Q4	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	419238
CY2011Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1320693
CY2011Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-220
CY2011Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	408783
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.71
CY2011Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	137448
CY2011Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1463833
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.25
CY2011Q4	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-58091
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-220
CY2011Q4	arwr	Noncontrolling Interest NoncontrollingInterest	201294
CY2011Q4	arwr	Gain On Acquisition GainOnAcquisition	1576107
CY2011Q4	arwr	Facility And Equipment Rent Expense FacilityAndEquipmentRentExpense	90000
CY2011Q4	arwr	Proceeds From Sale Of Stock In Subsidiary ProceedsFromSaleOfStockInSubsidiary	8000
CY2011Q4	arwr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue	1392584
CY2012Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2012Q4	dei	Document Type DocumentType	10-Q
CY2012Q4	dei	Document Period End Date DocumentPeriodEndDate	2012-12-31
CY2012Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000879407
CY2012Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2012Q4	dei	Trading Symbol TradingSymbol	ARWR
CY2012Q4	dei	Entity Registrant Name EntityRegistrantName	ARROWHEAD RESEARCH CORP
CY2012Q4	dei	Amendment Flag AmendmentFlag	false
CY2012Q4	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2012Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	239605
CY2012Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2012Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	449597
CY2012Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	14208
CY2012Q4	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-18
CY2012Q4	us-gaap	Utilities Costs UtilitiesCosts	16000
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2012Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	12441
CY2012Q4	us-gaap	Profit Loss ProfitLoss	-4780727
CY2012Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	-4000	shares
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y2M12D
CY2012Q4	us-gaap	Other Income OtherIncome	22685
CY2012Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2013-11-26
CY2012Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	395675
CY2012Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	Company effected a 1 for 10 reverse stock split
CY2012Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1576666
CY2012Q4	us-gaap	Interest Paid InterestPaid	11114
CY2012Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14113620	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2012Q4	us-gaap	Share Based Compensation ShareBasedCompensation	395675
CY2012Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.54
CY2012Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3837586
CY2012Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-446256
CY2012Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-157208
CY2012Q4	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	111979
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4810021
CY2012Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-18
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2012Q4	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3279369
CY2012Q4	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	53098
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-4614159
CY2012Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	29312
CY2012Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	105891
CY2012Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2012Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4780709
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2012Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	917676
CY2012Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	572
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.69	pure
CY2012Q4	us-gaap	Proceeds From Customers ProceedsFromCustomers	300000
CY2012Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7416
CY2012Q4	us-gaap	Operating Expenses OperatingExpenses	4969037
CY2012Q4	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1000000
CY2012Q4	us-gaap	Revenues Revenues	159016
CY2012Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P12Y
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2012Q4	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	44275
CY2012Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-166568
CY2012Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9439
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	274451
CY2012Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-63557
CY2012Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	18493
CY2012Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	395674
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4780709
CY2012Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1629423
CY2012Q4	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Use of Estimates</i></font></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Actual results could differ from those estimates.</font></font></p> </div>
CY2012Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3300000
CY2012Q4	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	-63557
CY2012Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74115
CY2012Q4	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-18
CY2012Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-18
CY2012Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	111865
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.51
CY2012Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-68459
CY2012Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3332467
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2012Q4	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	121418
CY2012Q4	arwr	Noncontrolling Interest NoncontrollingInterest	166568
CY2012Q4	arwr	Subscription Receivable SubscriptionReceivable	16000
CY2012Q4	arwr	Facility And Equipment Rent Expense FacilityAndEquipmentRentExpense	145000
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.33
CY2012Q4	us-gaap	Debt Instrument Payment Terms DebtInstrumentPaymentTerms	Two times principal payment upon certain events
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-18
CY2012Q4	arwr	Increase In Monthly Expenditure Due To Utilities Costs IncreaseInMonthlyExpenditureDueToUtilitiesCosts	72000
CY2012Q4	arwr	Obligation To Pay Royalties ObligationToPayRoyalties	Later of (i) the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii) ten years after the first commercial sale of such product candidate.
CY2012Q4	arwr	Other Rental Expenses OtherRentalExpenses	13000
CY2012Q4	arwr	Ownership Percentage In Subsidiary OwnershipPercentageInSubsidiary	1.00	pure
CY2012Q4	arwr	Period Of Revenue Milestones Considered For Contingent Payment PeriodOfRevenueMilestonesConsideredForContingentPayment	P10Y
CY2012Q4	arwr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue	6023
CY2012Q4	arwr	Term Of Exchange Rights TermOfExchangeRights	P7Y
CY2012Q4	arwr	Present Value Of Contingent Acquisition Consideration PresentValueOfContingentAcquisitionConsideration	84935

Files In Submission

Name	View Source	Status
0001193125-13-055330-index-headers.html	Edgar Link	pending
0001193125-13-055330-index.html	Edgar Link	pending
0001193125-13-055330.txt	Edgar Link	pending
0001193125-13-055330-xbrl.zip	Edgar Link	pending
arwr-20121231.xml	Edgar Link	completed
arwr-20121231.xsd	Edgar Link	pending
arwr-20121231_cal.xml	Edgar Link	unprocessable
arwr-20121231_def.xml	Edgar Link	unprocessable
arwr-20121231_lab.xml	Edgar Link	unprocessable
arwr-20121231_pre.xml	Edgar Link	unprocessable
d465596d10q.htm	Edgar Link	pending
d465596dex311.htm	Edgar Link	pending
d465596dex312.htm	Edgar Link	pending
d465596dex321.htm	Edgar Link	pending
d465596dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARWR
ARROWHEAD PHARMACEUTICALS, INC. Stock $arwr

2013 Q1 Form 10-Q Financial Statement

#000119312513055330 Filed on February 13, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARWR ARROWHEAD PHARMACEUTICALS, INC. Stock $arwr

2013 Q1 Form 10-Q Financial Statement

#000119312513055330 Filed on February 13, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARWR
ARROWHEAD PHARMACEUTICALS, INC. Stock $arwr